Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Aug '25 Aug 8, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Market Capitalization	1,057	757	465	34	73	21	Upgrade
Market Cap Growth	65.26%	62.65%	1252.71%	-53.05%	248.25%	-26.92%	Upgrade
Enterprise Value	1,172	773	401	10	31	-20	Upgrade
Last Close Price	178.70	146.85	104.19	9.32	19.85	5.70	Upgrade
PE Ratio	30.59	47.80	104.93	-	-	4.01	Upgrade
PS Ratio	2.07	2.25	47.78	15.52	42.71	2.52	Upgrade
PB Ratio	4.16	2.98	3.52	0.53	1.18	0.33	Upgrade
P/TBV Ratio	8.15	5.84	3.52	0.53	1.18	0.33	Upgrade
P/FCF Ratio	-	-	-	-	4.45	-	Upgrade
P/OCF Ratio	-	-	-	-	4.45	-	Upgrade
EV/Sales Ratio	2.30	2.29	41.16	4.59	18.12	-	Upgrade
EV/EBITDA Ratio	-	25.67	-	-	-	-	Upgrade
EV/EBIT Ratio	27.69	25.89	67.66	-	122.79	-	Upgrade
EV/FCF Ratio	-	-	-	-	1.89	-	Upgrade
Debt / Equity Ratio	0.29	0.29	-	-	-	-	Upgrade
Debt / EBITDA Ratio	-	2.47	-	-	-	-	Upgrade
Asset Turnover	-	0.99	0.10	0.04	0.03	0.13	Upgrade
Quick Ratio	-	0.62	82.35	91.02	175.27	46.76	Upgrade
Current Ratio	-	1.33	108.09	91.39	176.22	46.76	Upgrade
Return on Equity (ROE)	-	13.79%	4.50%	-0.16%	-0.53%	8.66%	Upgrade
Return on Assets (ROA)	-	5.50%	3.73%	-0.08%	0.25%	6.77%	Upgrade
Return on Capital (ROIC)	11.49%	8.10%	3.76%	-0.08%	0.25%	6.96%	Upgrade
Return on Capital Employed (ROCE)	-	11.70%	4.50%	-	0.40%	10.70%	Upgrade
Earnings Yield	2.00%	2.09%	0.95%	-0.29%	-0.45%	24.91%	Upgrade
FCF Yield	-	-13.79%	-5.98%	-6.09%	22.48%	-106.28%	Upgrade
Buyback Yield / Dilution	0.46%	21.21%	-12.75%	-7.32%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.